<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0A32DF0B-F2C5-42D5-A74A-32E1FD6B47D1"><gtr:id>0A32DF0B-F2C5-42D5-A74A-32E1FD6B47D1</gtr:id><gtr:name>University of Massachusetts (UMass)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0AEFDD04-383A-4977-9F05-440376448760"><gtr:id>0AEFDD04-383A-4977-9F05-440376448760</gtr:id><gtr:name>International Centre for Genetic Engineering and Biotechnology</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5FEE5E83-79D6-4AD2-970E-F076F1AC08A7"><gtr:id>5FEE5E83-79D6-4AD2-970E-F076F1AC08A7</gtr:id><gtr:name>Biodim Laboratory</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/83943EFB-3518-459A-B681-62475A559C89"><gtr:id>83943EFB-3518-459A-B681-62475A559C89</gtr:id><gtr:name>Whitehead Institute for Biomedical Research</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CD6AF5C3-2280-4421-911E-1D68A6DFFE7C"><gtr:id>CD6AF5C3-2280-4421-911E-1D68A6DFFE7C</gtr:id><gtr:name>University of Wuerzburg</gtr:name><gtr:address><gtr:line1>Sanderring 2</gtr:line1><gtr:postCode>D-97070</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/64F5B912-92CD-489B-A071-6CA22EFAAAA9"><gtr:id>64F5B912-92CD-489B-A071-6CA22EFAAAA9</gtr:id><gtr:name>Weizmann Institute of Science</gtr:name><gtr:address><gtr:line1>PO Box 26</gtr:line1><gtr:line2>Rehovot 76100</gtr:line2><gtr:line4>Rehovot</gtr:line4><gtr:postCode>76100</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Israel</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/453DB5AB-8BFE-4E0A-B761-1C39BD880D5D"><gtr:id>453DB5AB-8BFE-4E0A-B761-1C39BD880D5D</gtr:id><gtr:name>Scripps Research Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Immunology and Molecular Pathology</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0A32DF0B-F2C5-42D5-A74A-32E1FD6B47D1"><gtr:id>0A32DF0B-F2C5-42D5-A74A-32E1FD6B47D1</gtr:id><gtr:name>University of Massachusetts (UMass)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0AEFDD04-383A-4977-9F05-440376448760"><gtr:id>0AEFDD04-383A-4977-9F05-440376448760</gtr:id><gtr:name>International Centre for Genetic Engineering and Biotechnology</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5FEE5E83-79D6-4AD2-970E-F076F1AC08A7"><gtr:id>5FEE5E83-79D6-4AD2-970E-F076F1AC08A7</gtr:id><gtr:name>Biodim Laboratory</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/83943EFB-3518-459A-B681-62475A559C89"><gtr:id>83943EFB-3518-459A-B681-62475A559C89</gtr:id><gtr:name>Whitehead Institute for Biomedical Research</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CD6AF5C3-2280-4421-911E-1D68A6DFFE7C"><gtr:id>CD6AF5C3-2280-4421-911E-1D68A6DFFE7C</gtr:id><gtr:name>University of Wuerzburg</gtr:name><gtr:address><gtr:line1>Sanderring 2</gtr:line1><gtr:postCode>D-97070</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/64F5B912-92CD-489B-A071-6CA22EFAAAA9"><gtr:id>64F5B912-92CD-489B-A071-6CA22EFAAAA9</gtr:id><gtr:name>Weizmann Institute of Science</gtr:name><gtr:address><gtr:line1>PO Box 26</gtr:line1><gtr:line2>Rehovot 76100</gtr:line2><gtr:line4>Rehovot</gtr:line4><gtr:postCode>76100</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Israel</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/453DB5AB-8BFE-4E0A-B761-1C39BD880D5D"><gtr:id>453DB5AB-8BFE-4E0A-B761-1C39BD880D5D</gtr:id><gtr:name>Scripps Research Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/5908AE28-52DA-49ED-A8B3-B78D85922CBE"><gtr:id>5908AE28-52DA-49ED-A8B3-B78D85922CBE</gtr:id><gtr:firstName>Gregory</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Towers</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B654ECEC-1671-4888-9A24-6A3246332A48"><gtr:id>B654ECEC-1671-4888-9A24-6A3246332A48</gtr:id><gtr:firstName>Jeremy</gtr:firstName><gtr:otherNames>Alexander</gtr:otherNames><gtr:surname>Garson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/56CB866B-A1A5-4104-8DB7-5CD2846A339B"><gtr:id>56CB866B-A1A5-4104-8DB7-5CD2846A339B</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Griffiths</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/BA08691A-0277-45FB-A759-056325F7766E"><gtr:id>BA08691A-0277-45FB-A759-056325F7766E</gtr:id><gtr:firstName>Arne</gtr:firstName><gtr:otherNames>Nalpon</gtr:otherNames><gtr:surname>Akbar</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/74389446-0D26-451F-BC60-01028C798AAD"><gtr:id>74389446-0D26-451F-BC60-01028C798AAD</gtr:id><gtr:firstName>Mala</gtr:firstName><gtr:otherNames>Kunti</gtr:otherNames><gtr:surname>Maini</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D5568E1D-EFE4-448E-821B-3B135E754B5D"><gtr:id>D5568E1D-EFE4-448E-821B-3B135E754B5D</gtr:id><gtr:firstName>Yasuhiro</gtr:firstName><gtr:surname>Takeuchi</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F3AC79FF-5DA2-409B-9C45-6E9781A7AFF3"><gtr:id>F3AC79FF-5DA2-409B-9C45-6E9781A7AFF3</gtr:id><gtr:firstName>Jane</gtr:firstName><gtr:otherNames>Amanda</gtr:otherNames><gtr:surname>Skok</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/EBA4ABCD-0394-4234-8808-94480506F83D"><gtr:id>EBA4ABCD-0394-4234-8808-94480506F83D</gtr:id><gtr:firstName>Mary</gtr:firstName><gtr:surname>Collins</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/55B795C4-621C-41B7-8489-FDF214BD3B8E"><gtr:id>55B795C4-621C-41B7-8489-FDF214BD3B8E</gtr:id><gtr:firstName>J?rgen</gtr:firstName><gtr:surname>Roes</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9B8AD86D-047F-4ED8-9132-A04425B9A510"><gtr:id>9B8AD86D-047F-4ED8-9132-A04425B9A510</gtr:id><gtr:firstName>Wendy</gtr:firstName><gtr:surname>Barclay</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C79F2084-3844-4F18-BB91-8CF3F33A1361"><gtr:id>C79F2084-3844-4F18-BB91-8CF3F33A1361</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:otherNames>Seton</gtr:otherNames><gtr:surname>Tedder</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/60A6B3BA-CD5D-4C79-B4A6-327FF39DE1AB"><gtr:id>60A6B3BA-CD5D-4C79-B4A6-327FF39DE1AB</gtr:id><gtr:firstName>Ariberto</gtr:firstName><gtr:surname>Fassati</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/36906F8E-5D84-4FA7-A29C-914D210CD13F"><gtr:id>36906F8E-5D84-4FA7-A29C-914D210CD13F</gtr:id><gtr:firstName>Duncan</gtr:firstName><gtr:surname>Clark</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8EEFEE58-E369-4F4C-86BF-3AAE616C59E5"><gtr:id>8EEFEE58-E369-4F4C-86BF-3AAE616C59E5</gtr:id><gtr:firstName>Tim J</gtr:firstName><gtr:surname>Harrison</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C8928265-0C59-49F5-95D1-5CD184FBEF8B"><gtr:id>C8928265-0C59-49F5-95D1-5CD184FBEF8B</gtr:id><gtr:firstName>Benny</gtr:firstName><gtr:surname>Chain</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F4C48495-1923-4707-89F9-8E633268BD2A"><gtr:id>F4C48495-1923-4707-89F9-8E633268BD2A</gtr:id><gtr:firstName>Deenan</gtr:firstName><gtr:surname>Pillay</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/4342E52F-F544-423C-A7B1-7CDB0D7EB5E0"><gtr:id>4342E52F-F544-423C-A7B1-7CDB0D7EB5E0</gtr:id><gtr:firstName>R</gtr:firstName><gtr:surname>Coffin</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/365B37B6-7E8D-4B2E-A39D-02E92F44F91E"><gtr:id>365B37B6-7E8D-4B2E-A39D-02E92F44F91E</gtr:id><gtr:firstName>Chris</gtr:firstName><gtr:surname>Boshoff</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/4CE725D8-3664-490D-85FF-36DCE66B3262"><gtr:id>4CE725D8-3664-490D-85FF-36DCE66B3262</gtr:id><gtr:firstName>Vincent</gtr:firstName><gtr:surname>Emery</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3A2D1CFF-D14D-409F-8B2F-D87FFE363AF2"><gtr:id>3A2D1CFF-D14D-409F-8B2F-D87FFE363AF2</gtr:id><gtr:firstName>Robin</gtr:firstName><gtr:surname>Weiss</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/ED7DFA83-26A3-4280-9A85-FEFBEF19AB03"><gtr:id>ED7DFA83-26A3-4280-9A85-FEFBEF19AB03</gtr:id><gtr:firstName>Aine</gtr:firstName><gtr:surname>McKnight</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G9721629"><gtr:id>8EBEE230-316B-455B-B3BC-FDA8F3AC4DA1</gtr:id><gtr:title>UCL Centre for Medical Molecular Virology</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G9721629</gtr:grantReference><gtr:abstractText>Persistent viral disease is a significant problem in the UK. 30,000 people are estimated to be living with HIV-1, the virus that causes AIDS and 50,000 people are carriers of hepatitis B, which causes chronic liver disease. Viral infection also hampers advanced medical technologies, such as bone marrow or liver transplantation. This Centre proposal aims to link groups working on basic virus biology, the response of patients to viruses and the development of new viral diagnostics and treaments.</gtr:abstractText><gtr:technicalSummary>The applicants aim to pursue their current peer-reviewed research programmes, with collaborations enhanced by the Medical Molecular Virology Centre. 
Our efforts are focused on persistent, pathogenic, human viral disease and we study:
(i) Virus/cell interactions: identification and study of cellular pathways involved in viral infection and oncogenesis.
(ii) Virus/host interactions: identification and study of pathways involved in viral immunity and pathogenesis. 
(iii) Translational research: learning facets of basic virology from clinical studies and applying basic knowledge from the above programmes to improve diagnosis and treatment.</gtr:technicalSummary><gtr:fund><gtr:end>2010-01-23</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2001-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>927754</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Infection and Immunity</gtr:department><gtr:description>Novel broadly neutralizing Llama VHH (FASSATI)</gtr:description><gtr:id>05B3C6CB-3497-41B9-A3C3-EE903D45A843</gtr:id><gtr:impact>One paper to be submitted shortly.</gtr:impact><gtr:outcomeId>RvkADcwunwK-1</gtr:outcomeId><gtr:partnerContribution>Characterised VHH, area of binding, performed deep sequencing to demonstrate that novel VHH arised after immunization.</gtr:partnerContribution><gtr:piContribution>Developed and performed high through put screening to identify novel broadly neutralizing LLama VHH, identified three new VHH.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Wurzburg</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Wuerzburg Collaboration (STAUSS)</gtr:description><gtr:id>12BB894B-7CF8-4488-A62B-30C9F1683BD8</gtr:id><gtr:impact>TBA</gtr:impact><gtr:outcomeId>cpYahGdnEHR-1</gtr:outcomeId><gtr:partnerContribution>TBA</gtr:partnerContribution><gtr:piContribution>TBA</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Clinical Sciences Centre (CSC)</gtr:department><gtr:description>MRC Clinical Sciences Centre (R JENNER)</gtr:description><gtr:id>B71A818A-06D3-4ECA-BDAC-C967ECF4E56B</gtr:id><gtr:impact>In progress</gtr:impact><gtr:outcomeId>WB6wnwKYuZ5-1</gtr:outcomeId><gtr:partnerContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:partnerContribution><gtr:piContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Biodim Laboratory</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Discovery of new cellular targets for antiretroviral drug development (FASSATI)</gtr:description><gtr:id>BE8ADAE2-3F91-4090-91BC-F11EDFE80714</gtr:id><gtr:impact>Eleven new hits identified to be followed up</gtr:impact><gtr:outcomeId>JqQZtLmmEDh-1</gtr:outcomeId><gtr:partnerContribution>Provided chemical library of 10,000 compounds to perform screening and cherry picked compounds.</gtr:partnerContribution><gtr:piContribution>Developed a novel cell-based, high through put screening assay. Discovered a new cell target important for HIV-1 infection.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>KCL Paul Lavender (R JENNER)</gtr:description><gtr:id>B3FA2058-8FD5-4788-86C5-3DB597165259</gtr:id><gtr:impact>resulting in publication 21876034</gtr:impact><gtr:outcomeId>BVmSYpbPoAz-1</gtr:outcomeId><gtr:partnerContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:partnerContribution><gtr:piContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Veronique Birault, GSK, Stevenage.</gtr:description><gtr:id>98C2803E-56F9-456E-AA4B-16069AA449C1</gtr:id><gtr:impact>In the process of performing SAR studies with GSK compounds</gtr:impact><gtr:outcomeId>5457b530bc2508.60866385-1</gtr:outcomeId><gtr:partnerContribution>Provided lead compounds that target the new host factor discovered by us.</gtr:partnerContribution><gtr:piContribution>Provided data on a new host factor to be used as an antiretroviral target.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Medical Molecular Virology</gtr:department><gtr:description>Professor Benny Chain, UCL and MRC Centre</gtr:description><gtr:id>52C6F8BD-0EF1-49EB-A980-BAB7EA3B85B8</gtr:id><gtr:impact>One MSc Thesis (Tse Wang) and one paper published in the journal Traffic</gtr:impact><gtr:outcomeId>5457ab20a51f24.87271310-1</gtr:outcomeId><gtr:partnerContribution>Provided data and expertise on biophysical properties of transfected DNA and on innate Immunity.</gtr:partnerContribution><gtr:piContribution>Provided data and expertise on nuclear import of DNA.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Infection and Immunity</gtr:department><gtr:description>Ari Fassati collaboration (R JENNER)</gtr:description><gtr:id>E1E6B179-E28A-4203-8D85-D1037E67743D</gtr:id><gtr:impact>na</gtr:impact><gtr:outcomeId>Ybe8AiJktGQ-1</gtr:outcomeId><gtr:partnerContribution>resulting in publication 20937817</gtr:partnerContribution><gtr:piContribution>intellectual input into research</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Biosciences</gtr:department><gtr:description>Hsp90 controls HIV-1 reactivation from latency (FASSATI)</gtr:description><gtr:id>E6401D01-C601-4C39-A67C-ACF8CD3A12C3</gtr:id><gtr:impact>One paper in PLoS Path (2012), one invited review in Parasitology (to be submitted shortly), one manuscript submitted and one MRC grant application submitted in September 2013.</gtr:impact><gtr:outcomeId>TwYz4sMJM3z-3</gtr:outcomeId><gtr:partnerContribution>Discovered that hyperthermia stimulates HIV-1 replication and reactivation. Contributed imaging methods to visualise nuclear migration of Hsp90 and other components.</gtr:partnerContribution><gtr:piContribution>Discovered that Hsp90 is required for HIV-1 gene expression and reactivation from latency, described the pathway involved.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Whitehead Institute for Biomedical Research</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Whitehead Inst Biomed Res (R JENNER)</gtr:description><gtr:id>24AB1335-8517-4ED8-A952-F4A3563DB1C4</gtr:id><gtr:impact>In progress</gtr:impact><gtr:outcomeId>DaFeNLW8PEt-1</gtr:outcomeId><gtr:partnerContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:partnerContribution><gtr:piContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Weizmann Institute of Science</gtr:collaboratingOrganisation><gtr:country>Israel, State of</gtr:country><gtr:description>Population dynamics of T cell responses analysed using high-throughput sequencing of TCR repertoire (CHAIN)</gtr:description><gtr:id>E2D09A07-E967-4FE3-BB9F-0B28ABFEEE85</gtr:id><gtr:impact>Still in progress</gtr:impact><gtr:outcomeId>YHN3NvnfLJg-1</gtr:outcomeId><gtr:partnerContribution>Immunisations and seqeuncing</gtr:partnerContribution><gtr:piContribution>Developemnt of software for seqeunce analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Llama VHHantobody fragments to neutralise viruses (WEISS)</gtr:description><gtr:id>586CDA17-A1CF-4BE5-81FA-866D9B238B73</gtr:id><gtr:impact>Research papers and 1 patent filed</gtr:impact><gtr:outcomeId>bRwMQNRPNYh-1</gtr:outcomeId><gtr:partnerContribution>VHH technology</gtr:partnerContribution><gtr:piContribution>virology</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Professor Olivier Schwartz, Pasteur Institute, Paris</gtr:description><gtr:id>74222979-447E-4659-94E3-E893BC046738</gtr:id><gtr:impact>One paper in PLoS Pathogens describing the effect of fever on HIV-1 replication and the role of Hsp90</gtr:impact><gtr:outcomeId>5457ac4d11b695.94540793-1</gtr:outcomeId><gtr:partnerContribution>Provided data and expertise on mechanisms contributing to enhanced HIV-1 replication during hyperthermia (fever).</gtr:partnerContribution><gtr:piContribution>Provided data and expertise on the role of Hsp90 in HIV-1 infection.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Medicine</gtr:department><gtr:description>UCL Dept Medicine (R JENNER)</gtr:description><gtr:id>57366B16-0145-431B-8E44-7CE9FE4DA6BD</gtr:id><gtr:impact>In progress</gtr:impact><gtr:outcomeId>RFZvUc32XBP-1</gtr:outcomeId><gtr:partnerContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:partnerContribution><gtr:piContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>UCL Cancer Institute</gtr:department><gtr:description>National Facility for GMP production of lentiviral and AAV vectors for gene therapy (MARY COLLINS)</gtr:description><gtr:id>88052D88-25D3-4B83-8E7E-E3BD93A4DC66</gtr:id><gtr:impact>in progress (publications)</gtr:impact><gtr:outcomeId>ZPaahSggF9F-1</gtr:outcomeId><gtr:partnerContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:partnerContribution><gtr:piContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Super-resolution imaging: probe development (GROVE)</gtr:description><gtr:id>326154B6-52B8-48ED-BF57-BDF62C8C3163</gtr:id><gtr:impact>not yet known</gtr:impact><gtr:outcomeId>VS3hguu22DK-1</gtr:outcomeId><gtr:partnerContribution>Project conception, development and application</gtr:partnerContribution><gtr:piContribution>Project conception, development and application</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Wellcome Trust Sanger Centre collaboration (DAN DEPLEDGE)</gtr:description><gtr:id>601F6C1D-3DBD-4B84-834B-922FD2C169E9</gtr:id><gtr:impact>In progress</gtr:impact><gtr:outcomeId>KPcCokDmArC-1</gtr:outcomeId><gtr:partnerContribution>Shared knowledge, materials and resources leading to publication output (in progress)</gtr:partnerContribution><gtr:piContribution>Shared knowledge, materials and resources leading to publication output (in progress)</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Prof. Olivier Schwartz, Pasteur Institute, Paris (FASSATI)</gtr:description><gtr:id>6083E27D-9CE7-44CF-A802-67B7D676B8F5</gtr:id><gtr:impact>One paper in PLoS Pathogens describing the effect of fever on HIV-1 replication and the role of Hsp90</gtr:impact><gtr:outcomeId>f5fSw2V8ESh-1</gtr:outcomeId><gtr:partnerContribution>Provided data and expertise on mechanisms contributing to enhanced HIV-1 replication during hyperthermia (fever)</gtr:partnerContribution><gtr:piContribution>Provided data and expertise on the role of Hsp90 in HIV-1 infection</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cancer Research UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Dr Peter Cherepanov, CRUK</gtr:description><gtr:id>FB927806-A627-4BB6-9FD7-26A9E3054231</gtr:id><gtr:impact>One paper in PNAS</gtr:impact><gtr:outcomeId>5457ad8c644f58.76072307-1</gtr:outcomeId><gtr:partnerContribution>Structural biology of transportin 3.</gtr:partnerContribution><gtr:piContribution>provision of expression constructs recomninat protein expression and methods for immunoprecipitation. Expertise on nuclear transport receptors.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Laboratory of Molecular Biology (LMB)</gtr:department><gtr:description>Restriction Factor Structure Function</gtr:description><gtr:id>5086B2E5-CA06-4C83-B8C9-107D17DBC527</gtr:id><gtr:impact>We have copublished PMIDs 21045130, 20808866, 19767750, 19073742
Collaboration is multidiciplinary in that we are molecular virologists and James is a biophysicist and protein crystallographer</gtr:impact><gtr:outcomeId>bgt3Wm1nspu-1</gtr:outcomeId><gtr:partnerContribution>The James lab has solved crystal structures of restriction factors and viral proteins and performed many biophysical and chemistry experiments allowing us to understand the mechanistic details of restriction factor virus interactions.</gtr:partnerContribution><gtr:piContribution>We have characterised host restriction factor relationships and evolution by collaborating with Leo James at the laboratory for Molecular Biology. Leo solves structures and performs biophysical measurements of protein/protein interactions and we characterise and assay mutant behavior thereby learning mechanistic molecular details of action and evolution.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>International Centre for Genetic Engineering and Biotechnology</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Hsp90 controls HIV-1 reactivation from latency (FASSATI)</gtr:description><gtr:id>7CBBB331-B41E-42EE-9790-0B16BA6C48B6</gtr:id><gtr:impact>One paper in PLoS Path (2012), one invited review in Parasitology (to be submitted shortly), one manuscript submitted and one MRC grant application submitted in September 2013.</gtr:impact><gtr:outcomeId>TwYz4sMJM3z-2</gtr:outcomeId><gtr:partnerContribution>Discovered that hyperthermia stimulates HIV-1 replication and reactivation. Contributed imaging methods to visualise nuclear migration of Hsp90 and other components.</gtr:partnerContribution><gtr:piContribution>Discovered that Hsp90 is required for HIV-1 gene expression and reactivation from latency, described the pathway involved.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>London Centre for Nanotechnology</gtr:department><gtr:description>London Centre for Nanotechnology (A FASSATI)</gtr:description><gtr:id>D42B8E2A-BE8C-438C-B2BF-7FB601669BB4</gtr:id><gtr:impact>a shared IMPACT PhD studentship for Dino Osmanovic</gtr:impact><gtr:outcomeId>issKpsD5DQq-1</gtr:outcomeId><gtr:piContribution>Collaboration with the London Centre for Nanotechnology (Bart Hoogemboom and Ian Ford), which resulted in a shared IMPACT PhD studentship for Dino Osmanovic</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Professor Mike Stratton and Dr Elisabeth Murchison, Wellcome Trust Sanger Institute</gtr:description><gtr:id>F08E3CB5-4DDA-4B63-865A-4151582B2C96</gtr:id><gtr:impact>A paper describing the CTVT genome published in Science, another publication on the tumour transcriptional changes is in preparation.</gtr:impact><gtr:outcomeId>5457b4217ac7b4.58853469-1</gtr:outcomeId><gtr:partnerContribution>Provided data and expertise on the genome of CTVT</gtr:partnerContribution><gtr:piContribution>Provided data and expertise on the canine Venereal Transmissible Tumour (CTVT).</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Scripps Research Institute</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Dennis Burton Lab Visit (MCCOY)</gtr:description><gtr:id>60B4B04E-7206-481F-9ABF-7307F85883E6</gtr:id><gtr:impact>not known yet</gtr:impact><gtr:outcomeId>aBNE6YgB9XE-1</gtr:outcomeId><gtr:partnerContribution>This travel grant was used to accelerate a HIV antigen development project</gtr:partnerContribution><gtr:piContribution>This travel grant was used to accelerate a HIV antigen development project</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Professor Christopher Moody and Dr Russell Kitson, University of Nottingham</gtr:description><gtr:id>F906A574-A079-4CB4-927F-618067B5B87C</gtr:id><gtr:impact>One paper in PNAS</gtr:impact><gtr:outcomeId>5457af169abe74.94468630-1</gtr:outcomeId><gtr:partnerContribution>Provided new chemical compounds inhibitors of Hsp90</gtr:partnerContribution><gtr:piContribution>Provided data and expertise on the role of Hsp90 in HIV-1 latency.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Infection and Immunity</gtr:department><gtr:description>UCL Paul Kellam (R JENNER)</gtr:description><gtr:id>7E900DC2-500D-48F7-BC8B-3C75FA4938CB</gtr:id><gtr:impact>awarded a grant of &amp;pound;99,940, outcomes (published material etc) yet to be recorded.</gtr:impact><gtr:outcomeId>XN1UqnE3m8p-1</gtr:outcomeId><gtr:piContribution>Collaboration with Paul Kellam resulting in a project grant from the UCLH/UCL Comprehensive Biomedical Research Centre.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Understanding the coordination of hepatitis C virus entry and humoral immune evasion (GROVE)</gtr:description><gtr:id>B99C0742-92F4-4187-AE2C-5EBB59C656A7</gtr:id><gtr:impact>not yet known</gtr:impact><gtr:outcomeId>LkAuGKtuzmr-1</gtr:outcomeId><gtr:partnerContribution>Access to clinical samples</gtr:partnerContribution><gtr:piContribution>Project conception, development and application</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Weizmann Institute of Science</gtr:collaboratingOrganisation><gtr:country>Israel, State of</gtr:country><gtr:description>WESTON VISITING PROFESSORSHIP (BENNY CHAIN)</gtr:description><gtr:id>E94AED94-A997-4CD2-BA68-3D6213BF7B0D</gtr:id><gtr:impact>Led to award of a bilateral Weizmann/UCL grant (Making Connections programme) $100,000 over two years.</gtr:impact><gtr:outcomeId>LELqddr5Fsj-1</gtr:outcomeId><gtr:partnerContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:partnerContribution><gtr:piContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Hsp90 controls HIV-1 reactivation from latency (FASSATI)</gtr:description><gtr:id>416D8567-9045-4713-96C5-B4525B02C42A</gtr:id><gtr:impact>One paper in PLoS Path (2012), one invited review in Parasitology (to be submitted shortly), one manuscript submitted and one MRC grant application submitted in September 2013.</gtr:impact><gtr:outcomeId>TwYz4sMJM3z-1</gtr:outcomeId><gtr:partnerContribution>Discovered that hyperthermia stimulates HIV-1 replication and reactivation. Contributed imaging methods to visualise nuclear migration of Hsp90 and other components.</gtr:partnerContribution><gtr:piContribution>Discovered that Hsp90 is required for HIV-1 gene expression and reactivation from latency, described the pathway involved.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Adrian Hill and Helen McShane Oxford supported by UCL CBRC grant (COLLINS)</gtr:description><gtr:id>A84E37CF-836B-420A-B79D-23931E7F3C2B</gtr:id><gtr:impact>in progress</gtr:impact><gtr:outcomeId>A82MeHbBbYV-1</gtr:outcomeId><gtr:partnerContribution>Novel adjuvant molecules, TB antigens and models</gtr:partnerContribution><gtr:piContribution>Lentiviral vectors</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Discovery of new cellular targets for antiretroviral drug development (FASSATI)</gtr:description><gtr:id>04AB5C57-5523-4383-B0BE-5C767612F7B2</gtr:id><gtr:impact>in the process of testing the compounds</gtr:impact><gtr:outcomeId>osYUkdksaMH-1</gtr:outcomeId><gtr:partnerContribution>Provided novel lead compounds that inhibit the target identified in our high through put screening</gtr:partnerContribution><gtr:piContribution>Developed a novel high through put screening, cell-based assay. Discovered a new cell target important for HIV</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Dr Marcus Dorner, Imperial College</gtr:description><gtr:id>1443EF50-7DFB-4B1F-BC24-3B09F924F207</gtr:id><gtr:impact>experiments ongoing</gtr:impact><gtr:outcomeId>5457b3383d17e7.56862711-1</gtr:outcomeId><gtr:partnerContribution>Humanized mouse models for HIV-1 infection to test the effect of selective Hsp90 inhbitors on HIV-1 latency.</gtr:partnerContribution><gtr:piContribution>Provided data and expertise on the effect of Hsp90 on regulation of HIV-1 latency, provided specific Hsp90 inhibitor.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC National Institute for Medical Research (NIMR)</gtr:department><gtr:description>Dr. Ian Taylor, MRC NIMR, Mill Hill (FASSATI)</gtr:description><gtr:id>22DCC985-D3CF-43EB-AC51-89008C423D7C</gtr:id><gtr:impact>one paper in preparation</gtr:impact><gtr:outcomeId>fJ4246Npm7o-1</gtr:outcomeId><gtr:partnerContribution>co-crystal structure of Coumermycin-A1 and HIV-1 capsid protein</gtr:partnerContribution><gtr:piContribution>Provided data and expertise on the role of the antibiotic Coumermycin-A1 in blocking HIV-1 replication</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>London Centre for Nanotechnology</gtr:department><gtr:description>Mechanism of viral transport across nuclear pores (FASSATI)</gtr:description><gtr:id>98C25C62-030E-4801-8080-F1D5CFE73780</gtr:id><gtr:impact>One modelling paper (Phys. Rev. E. 2012), one review (Soft Matter 2013), one paper to be submitted shortly.</gtr:impact><gtr:outcomeId>GypEAdBAEgA-1</gtr:outcomeId><gtr:partnerContribution>Atomic force microscopy and physical modelling of nuclear pores.</gtr:partnerContribution><gtr:piContribution>Expertise on nucleo-cytoplasmic trafficking of viruses and large molecules.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Massachusetts (UMass)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Raymond Welsh Lab Visit (PEPPA)</gtr:description><gtr:id>A39C629C-8392-43B1-A9F9-0DF12C2AD7D2</gtr:id><gtr:impact>not yet known</gtr:impact><gtr:outcomeId>MjPBRLnXn2u-1</gtr:outcomeId><gtr:partnerContribution>development of valuable collaboration, also link with a planned project on regulatory potential of NK cells in HBV with the MRC unit in the Gambia</gtr:partnerContribution><gtr:piContribution>address how T cell regulation by NK cells contribute to overall disease pathogenesis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Metbolism and Endocrinology</gtr:department><gtr:description>Dr Richard Benarous, Mutabilis, France</gtr:description><gtr:id>F7CD0E37-6465-4414-B964-261281EF0139</gtr:id><gtr:impact>Identified four new compounds with antiretroviral activity: they belong to a new class of antiretrovirals .</gtr:impact><gtr:outcomeId>5457b6521ba981.38549373-1</gtr:outcomeId><gtr:partnerContribution>Provided expertise and library of 10,000 small chemical compounds selected from a 150,000 compounds library.</gtr:partnerContribution><gtr:piContribution>Performed novel high through put screening to identify host factos necessary for HIV-1 replication.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Professor Charles Bangham, Imperial College</gtr:description><gtr:id>57128008-A0C9-43F5-A2CC-025DDD06CBEA</gtr:id><gtr:impact>One paper in preparation, one grant application submitted to MRC.</gtr:impact><gtr:outcomeId>5457b2501774e5.76621581-1</gtr:outcomeId><gtr:partnerContribution>High through put sequencing of HIV-1 integration sites.</gtr:partnerContribution><gtr:piContribution>Discovered new host factor involved in HIV-1 replication that affects integration site selection.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visit, London (3 visits)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>775328B9-171B-4A15-B78C-B0D7F9D30F1F</gtr:id><gtr:impact>50+ 6th form Biology students attended a talk given by Prof Mary Collins on both Virology and science careers.

Provided further insights to virology and encouraged studetns further in choosing scientific careers</gtr:impact><gtr:outcomeId>dw2NUHn8k6r</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public lecture (STAUSS)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>137BA86D-6242-4D34-844F-B41E3B4BC678</gtr:id><gtr:impact>Approximately 200 lay people attended lecture on T Cell therapy

Lecture was recorded and is available on You-tube</gtr:impact><gtr:outcomeId>WAaSXnz3BP6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Carolton Primary School Visit 2012 (TOWERS/MILNE)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>CA2ECADE-ECC4-46A5-A734-E343B2C793F0</gtr:id><gtr:impact>40 local school children attended open day in the Centre labs; consisted of interactive introductory talk, followed by lab rotations where pupils preformed DNA extractions, microscope work, pipetting skills, artwork. Pupils asked many questions and the Centre received thank you letters expressing their increases interest in science and had a unique opportunity to do real lab-based tasks.</gtr:impact><gtr:outcomeId>LYRo1vX4bhv</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Live comment on the origin of the AIDS epidemic on Arise News (A. Fassati)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>07E92AA3-7199-4B87-8132-BC1396788DDD</gtr:id><gtr:impact>to be added</gtr:impact><gtr:outcomeId>545a4ceb7ae763.69277745</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.arise.tv/arise-news-show/africa-wrap-03-10-8501</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Work experience pupils (x4)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:id>3187DAD7-82DE-4FDD-91A2-E9FFA2244ED6</gtr:id><gtr:impact>high school students attending 1 week work experience placements in various member's labs; shadowing staff and performing experiments

Provided further encouragement to take further study/career directions in virology or biomedical sciences</gtr:impact><gtr:outcomeId>rHmWfaTeb77</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Contribution to the Financial Times &quot;New synthetic life needs context and regulation&quot;(A. Fassati)</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>350FA4AD-ACEE-455E-B176-3D7384026FFF</gtr:id><gtr:impact>to be added</gtr:impact><gtr:outcomeId>545a503dc26947.02633876</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.ft.com/cms/s/0/3da6db20-6796-11df-a932-00144feab49a.html#axzz2hsOEkNfY</gtr:url><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Thomas More Institute talk (A FASSATI)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>8CF57C8B-8162-4DA9-BEF5-6FCD0A0A0E37</gtr:id><gtr:impact>presented talk titled 'Conscience and Values in the Response to Infectious Diseases' given to 50+ adult members of the public

na</gtr:impact><gtr:outcomeId>A1xVzZUpZyf</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School Visit Primrose Hill (STAUSS)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>42063638-A7B5-4374-B857-E835282F6B4C</gtr:id><gtr:impact>Parents attended a presentation of our research and all children attended an assembly

money raised for cancer research</gtr:impact><gtr:outcomeId>YBeV66JFrWi</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Mayflower &amp; Gayhurst Primary schools visits 2012 (TOWERS/MILNE)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>262A3BE5-5799-458D-A16E-2F2DA805C9CE</gtr:id><gtr:impact>Centre members visited local schools and presented an interactive talk about virology. Pupils asked many questions and the Centre received thank you letters expressing their increases interest in science and had a unique opportunity to do real lab-based tasks.</gtr:impact><gtr:outcomeId>oQdCZa47d1T</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Institute of Arts talk (M COLLINS)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>CDB93677-D906-41B5-8B3E-0A3F7D272C68</gtr:id><gtr:impact>presented talk titled 'Are Women Changing Science?'

na</gtr:impact><gtr:outcomeId>AtFwP8JVbAS</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>mothers2mothers charity talk (A FASSATI)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>B0077B36-79A4-488D-BBB2-4D11D6716448</gtr:id><gtr:impact>presented talk titled 'The Current AIDS Epidemic' to 25+ members of the adult public

all proceeds to mothers2mothers charity</gtr:impact><gtr:outcomeId>iyCSiDQGcTz</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>HIV &amp; AIDS (WEISS)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>3C85218B-5EEA-42B1-8106-34F894A133EF</gtr:id><gtr:impact>too soon to say</gtr:impact><gtr:outcomeId>Yynt4xSYLKL</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Institute of Immunity and Transplantation Opening Symposium (GROVE)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>08854C51-A5F9-4BD2-B827-4EA5972A4B07</gtr:id><gtr:impact>The symposium was filmed and I worked with a video editor to create a digital version of the presentation for You Tube</gtr:impact><gtr:outcomeId>jFrjQxtVRof</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Social Mobility Foundation Students (G TOWERS)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:id>6B24F331-E582-4524-A8F6-BDDAE9391349</gtr:id><gtr:impact>We took 2 students for a week each in August.

The idea is that students from poor backgrounds who wouldnt normally be exposed to opportunities for work experience can be helped out.</gtr:impact><gtr:outcomeId>qXEWhb1QBUn</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Mayflower &amp; Gayhurst Primary School visits 2013 (TOWERS/MILNE)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>E649304A-7910-43D6-A176-A41D1FFBAE31</gtr:id><gtr:impact>Centre members visited local schools and presented an interactive talk about virology. Pupils asked many questions and the Centre received thank you letters expressing their increases interest in science and had a unique opportunity to do real lab-based tasks.</gtr:impact><gtr:outcomeId>kRKg9aLvttF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Observer Interview (M COLLINS)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>E60ECB88-44DD-49DA-BDD5-11226D5C3AE3</gtr:id><gtr:impact>&amp;quot;My Bright Idea&amp;quot;- Interview for The Observer, 24/4/11

na</gtr:impact><gtr:outcomeId>kk4jfoZcqF2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit (x2), 2011</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:id>9E7F602A-1484-4168-8286-D0B808E043CD</gtr:id><gtr:impact>R Milne &amp;amp; G Towers visited 2 primary schools (Gayhurst and Mayflower), various activities for 50+ pupils

received many thank you letters and further questions from pupils</gtr:impact><gtr:outcomeId>e5djDHcErA6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture to Y6 children &quot;Investigating microbes&quot; at the Oratory RC Primary School, London. (A. Fassati)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>01FD7A30-DFDF-4688-A8B3-1C115E78C0DE</gtr:id><gtr:impact>to be added</gtr:impact><gtr:outcomeId>545a4d88a239c4.34174376</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk in Bloomsbury Festival (M COLLINS)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>6443B679-7CC9-4ACC-94F1-DC404EA8FE8A</gtr:id><gtr:impact>Cosy Science, &amp;quot;viruses are our friends&amp;quot;, The Marquis of Cornwallis pub, 2013 for 50+ local residents

raised public awareness</gtr:impact><gtr:outcomeId>rjJ3xB6Jpyc</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture on the AIDS epidemic for the charity &quot;Mothers to Mothers&quot; London. (A. Fassati)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>F9CA4158-3A91-4780-B1AD-A7276187F52F</gtr:id><gtr:impact>to be added</gtr:impact><gtr:outcomeId>545a4faae7f4d3.96174765</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.m2m.org</gtr:url><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lunchtime Lecture UCL (COLLINS)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>3436EEB3-F691-4776-A83A-3EF77D030841</gtr:id><gtr:impact>800 You tube hits</gtr:impact><gtr:outcomeId>Sp3KFk8iPsm</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC@UCL Centenary Science Fair (ALL MEMBERS)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>92D563C7-6EF7-417D-8788-AAE83909E3DD</gtr:id><gtr:impact>500+ members of the public (families, adults, school children) attended a science fair held @ UCL, Centre members contributed 3 hands-on workshop stalls, and presented separate talks. The public were given opportunities to perform tasks associated with the work of the Centre, and asked questions/contributed to discussions about what the Centre does and general science queries. Feedback included saying children had increased interest in developing their science education and awareness of virology principles.</gtr:impact><gtr:outcomeId>p3GGr2CsPNH</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture &quot;Conscience and values in the response to infectious diseases&quot;, Thomas More Institute, London. (A. Fassati)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>AEC13522-FD01-4FD7-95D2-B7839EFAE2F7</gtr:id><gtr:impact>to be added</gtr:impact><gtr:outcomeId>545a4ef0d3d475.73242472</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://thomasmoreinstitute.org.uk/papers/conscience-and-values-in-the-response-toinfectious-diseases/</gtr:url><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture: City of London Boyrs School (B CHAIN)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>DEFF24FE-5989-4D68-B38B-12EFA492E6C2</gtr:id><gtr:impact>50+ pupils attended a lecture titled 'vaccinations'

na</gtr:impact><gtr:outcomeId>MuijEhdnd2i</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>237518</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant (R JENNER)</gtr:description><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>617FFF4B-8CE3-4F21-819A-525AF751CCC7</gtr:id><gtr:outcomeId>DsmkPR5ztg20</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>180000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK research grant (M COLLINS)</gtr:description><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>F9D2C601-F1B3-4223-8971-27FE3237EF4C</gtr:id><gtr:outcomeId>fthfeLuov4u0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6000000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>EU FP7 HEALTH 2012 INNOVATION-1 (STAUSS)</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>DAF9E959-EB87-4F3D-AAE7-9D25FA1DB178</gtr:id><gtr:outcomeId>Mb3Ap4HxJFk</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>140888</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>UCLH/UCL Biomedical Research Centre</gtr:department><gtr:description>Biomedical Research Centre research grant (M COLLINS)</gtr:description><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>7773419E-9AD8-4008-AFF3-E01988490074</gtr:id><gtr:outcomeId>hthLNCAWtoi0</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>520000</gtr:amountPounds><gtr:country>Hungary, Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Biological Research Centre (BRC)</gtr:department><gtr:description>UCLH BRC Funding for Wolfson Gene Therapy Unit, 2013-2016 (M. Collins)</gtr:description><gtr:end>2016-01-02</gtr:end><gtr:fundingOrg>Hungarian Academy of Sciences (MTA)</gtr:fundingOrg><gtr:id>5B9835D6-CC21-401A-B7D7-972BD9C1B15C</gtr:id><gtr:outcomeId>546229937c0661.25620922</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>25000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD studentship (MARY COLLINS)/University College London</gtr:description><gtr:end>2009-02-02</gtr:end><gtr:fundingOrg>University College London</gtr:fundingOrg><gtr:id>03DEEC80-BD8C-470E-A78C-CA769E95A0FA</gtr:id><gtr:outcomeId>Lpi8TbKj6Vw0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>58000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>UCLH/UCL Biomedical Research Centre</gtr:department><gtr:description>CBRC grant award CBRC grant Measuring T cell repertoire perturbation in HIV infection (B CHAIN)</gtr:description><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>82BE2381-C0CF-4EA1-8499-DE1786F3DB1E</gtr:id><gtr:outcomeId>dD2HG7NtDcd0</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1559842</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Senior Research Fellowship in basic biomedical science</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>42A265FB-4F32-41F6-A780-EE846CD97F01</gtr:id><gtr:outcomeId>JU9NVmseyTg0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>37500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>LupusUK Consumables Fund (R JENNER)/LupusUK</gtr:description><gtr:fundingOrg>LUPUS UK</gtr:fundingOrg><gtr:id>F4B4A786-72A2-42E2-BFE8-C18C4962C4DF</gtr:id><gtr:outcomeId>iPVjFAnbfru0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PROJECT GRANT (BENNY CHAIN)/GATES FOUNDATION GRAND CHALLENGE GRANT</gtr:description><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:id>46CEF389-A9E6-4C41-B90F-3D610E895867</gtr:id><gtr:outcomeId>c3REKu9Px8h0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50711</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EMBO Long-Term Fellowship (R JENNER)</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>European Molecular Biology Organisation</gtr:fundingOrg><gtr:id>603D51EF-B9A4-46F5-81E1-54C160B1E2DE</gtr:id><gtr:outcomeId>HkXfaZRuzrM0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>12000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Rosetrees: relationship between vitamin D deficiency and the immune response (B CHAIN)</gtr:description><gtr:fundingOrg>Rosetrees Trust</gtr:fundingOrg><gtr:id>20E526EE-FB14-4913-B6A7-72FBFE80F465</gtr:id><gtr:outcomeId>e3BqCjWnU2r0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>20000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship - Khaled Sanber (M COLLINS)</gtr:description><gtr:fundingOrg>University College London</gtr:fundingOrg><gtr:id>76C33095-7E3A-4E35-A59C-BC0836F3044A</gtr:id><gtr:outcomeId>KMKhL2nG8Hw0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>NA</gtr:description><gtr:grantRef>G9721629</gtr:grantRef><gtr:id>403C74B6-0C96-450C-B84C-497BE9FEE838</gtr:id><gtr:impact>NA</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:outcomeId>cM5nXyiHoUX</gtr:outcomeId><gtr:patentId>GB1015305.4</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>patent application # 1015305.4 (R JENNER)</gtr:title><gtr:yearProtectionGranted>2010</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>EMBO course (MARY COLLINS)</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>51CC04DD-1899-4EAD-A414-828FA9723FE6</gtr:id><gtr:impact>Provided advancement of training in this area to postgraduate+ level audiences</gtr:impact><gtr:outcomeId>ikc1gTT8k3Z</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>FSA-MRC joint workshop (BENNY CHAIN)</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>47357A5E-7A3B-45EE-935F-5AD74D3283D8</gtr:id><gtr:impact>Participant in owrkshop which promotes opportunities for synergy between basic immunology and food allergy research</gtr:impact><gtr:outcomeId>NSzi8zyNjxg</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>SAB CIRI, Lyon (M COLLINS)</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>5A11783D-F425-467A-8E8C-B17E44224F31</gtr:id><gtr:impact>improved research practices at CIRI</gtr:impact><gtr:outcomeId>RSG9ChjkZyV</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>INSERM lentiviral vector course (MARY COLLINS)</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>611269AB-411F-4568-ABFF-CFD7A1857FE7</gtr:id><gtr:impact>Provided advancement of training in this area to postgraduate+ level audiences</gtr:impact><gtr:outcomeId>CUs1a4i9Gir</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Unilver sponsored workshop (BENNY CHAIN)</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>5123BF2E-3E2C-41EC-B1C5-7BF10ACFD60B</gtr:id><gtr:impact>Invited planer speaker for 'T-lymphocytes: Orcehstrators of skin sensitisation'.</gtr:impact><gtr:outcomeId>U4edxhzvXgk</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member sub-panel 1, REF (M COLLINS)</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>41A45C8C-4019-47D2-9A4F-B670707D895B</gtr:id><gtr:impact>contribution to determining research standards of national institutes</gtr:impact><gtr:outcomeId>A7ozvVLmxaa</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>'Bench to Bedside' PhD programme (BENNY CHAIN)</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>72FB03EB-9270-43E3-9698-9D2906025D57</gtr:id><gtr:impact>Newly established studentship scheme providing translational context for basic sceince PhDs in area of Infection &amp;amp; Immunity</gtr:impact><gtr:outcomeId>TP4sNBEKb2S</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of DH Gene and Stem Cell therapy advisory committee (MARY COLLINS)</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>902639F1-13F3-4C30-94CE-5A4EBCF25272</gtr:id><gtr:impact>Provides advice on policy and safety at national level</gtr:impact><gtr:outcomeId>FXTZECtDEya</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>SAB Heinrich Pette Institute (M COLLINS)</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>48776C4F-00A8-4E3A-921C-4F485240AE9E</gtr:id><gtr:impact>improved research practices at the Institute</gtr:impact><gtr:outcomeId>E3LkT11U1j7</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Analysis pipeline for ChIP-Seq data</gtr:description><gtr:id>899822FC-9769-4386-AB06-94C3A7EBA00B</gtr:id><gtr:impact>Aid the research of own and other groups in this field, useful resource tool</gtr:impact><gtr:outcomeId>Zc8iWZ6gKTd</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Analysis pipeline for ChIP-Seq data (R JENNER)</gtr:title><gtr:type>Data analysis technique</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Database short RNAs transcribed in CD4+ T-cells</gtr:description><gtr:id>7B582059-43AB-40BC-A7A9-9AC39D8F5411</gtr:id><gtr:impact>Aid the research of own and other groups in this field, useful resource tool</gtr:impact><gtr:outcomeId>brkGcwr5ySF</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Database short RNAs transcribed in CD4+ T-cells (R JENNER)</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Mouse gene knockout of cathepsin E (aspartic proteinase involved in immune function)</gtr:description><gtr:id>3ECD151E-EF02-4334-8C85-18D5E36B2624</gtr:id><gtr:impact>offers the opportunity for further studies of cathepsin E in vivo based on this mouse model</gtr:impact><gtr:outcomeId>gMV6xo4MGmk</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Mouse gene knockout cathepsin E (BENNY CHAIN)</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>D30774F3-E679-4841-9233-6F9AC6B36115</gtr:id><gtr:title>PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8+ T cells.</gtr:title><gtr:parentPublicationTitle>EMBO molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/503b54c73715620166f20a676a65bbdb"><gtr:id>503b54c73715620166f20a676a65bbdb</gtr:id><gtr:otherNames>Karwacz K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1757-4676</gtr:issn><gtr:outcomeId>Zm4nmUL2geQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43735870-7DD2-4835-90E3-2CE2679F8D5B</gtr:id><gtr:title>Deep sequencing of viral genomes provides insight into the evolution and pathogenesis of varicella zoster virus and its vaccine in humans.</gtr:title><gtr:parentPublicationTitle>Molecular biology and evolution</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03f50fdda9533c73c407c979b78d57e2"><gtr:id>03f50fdda9533c73c407c979b78d57e2</gtr:id><gtr:otherNames>Depledge DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0737-4038</gtr:issn><gtr:outcomeId>545ba503861c55.58805226</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2253A087-CE38-4340-A5D3-03551272FE49</gtr:id><gtr:title>Targeted delivery of antigen processing inhibitors to antigen presenting cells via mannose receptors.</gtr:title><gtr:parentPublicationTitle>ACS chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e197a00ba92702c3846ba48558e422c4"><gtr:id>e197a00ba92702c3846ba48558e422c4</gtr:id><gtr:otherNames>Raiber EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1554-8929</gtr:issn><gtr:outcomeId>b3aQ6Uee5Ax</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13C78BCC-054D-4C9B-8610-8DE226E469BE</gtr:id><gtr:title>Endoplasmic reticulum degradation-enhancing a-mannosidase-like protein 1 targets misfolded HLA-B27 dimers for endoplasmic reticulum-associated degradation.</gtr:title><gtr:parentPublicationTitle>Arthritis &amp; rheumatology (Hoboken, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/439b5ba9e59cc5db5573c4d16339e4ab"><gtr:id>439b5ba9e59cc5db5573c4d16339e4ab</gtr:id><gtr:otherNames>Guiliano DB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2326-5191</gtr:issn><gtr:outcomeId>545ce81ebb64f2.77214785</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>53F83650-FD44-4E2C-8B38-D644F070BFC3</gtr:id><gtr:title>IL15 can reverse the unresponsiveness of Wilms' tumor antigen-specific CTL in patients with prostate cancer.</gtr:title><gtr:parentPublicationTitle>Clinical cancer research : an official journal of the American Association for Cancer Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/107069b077fbb6c4b8941b9da67b7b94"><gtr:id>107069b077fbb6c4b8941b9da67b7b94</gtr:id><gtr:otherNames>King JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1078-0432</gtr:issn><gtr:outcomeId>Y7c57PuwkvB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A42BDBC-CA9C-40B0-B964-362E13634E16</gtr:id><gtr:title>Inhibition of retroviral replication by members of the TRIM protein family.</gtr:title><gtr:parentPublicationTitle>Current topics in microbiology and immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4163edd090b7f7934101c6c7f3ffd2b9"><gtr:id>4163edd090b7f7934101c6c7f3ffd2b9</gtr:id><gtr:otherNames>Fletcher AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0070-217X</gtr:issn><gtr:outcomeId>545cf5bd1f1674.44388746</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B6EAD73F-DF4B-489E-B037-334E387CDC29</gtr:id><gtr:title>Lentiviral gene therapy against human immunodeficiency virus type 1, using a novel human TRIM21-cyclophilin A restriction factor.</gtr:title><gtr:parentPublicationTitle>Human gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f89c7b4622f2153cac81da53204ade0e"><gtr:id>f89c7b4622f2153cac81da53204ade0e</gtr:id><gtr:otherNames>Chan E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1043-0342</gtr:issn><gtr:outcomeId>pm_13996_26_22909012</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EAD0E24F-60D3-473F-955D-91C7D604A510</gtr:id><gtr:title>Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1468a3c79a930345b1162a38bc32d1aa"><gtr:id>1468a3c79a930345b1162a38bc32d1aa</gtr:id><gtr:otherNames>Gupta RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>NheKTrq4bG5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1103F7EA-094F-4BAB-B030-FF1CC92CAB87</gtr:id><gtr:title>Src-mediated regulation of inflammatory responses by actin polymerization.</gtr:title><gtr:parentPublicationTitle>Biochemical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ef082f96e626cce81f78fe979e8c994"><gtr:id>0ef082f96e626cce81f78fe979e8c994</gtr:id><gtr:otherNames>Kim JY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-2952</gtr:issn><gtr:outcomeId>Vj948Ph95qw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B96888EA-93AF-4631-8959-C3581ACFD17D</gtr:id><gtr:title>Wilms' Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responses.</gtr:title><gtr:parentPublicationTitle>British journal of haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6edbf63ed60ec50dcf00c4121c43bfc"><gtr:id>b6edbf63ed60ec50dcf00c4121c43bfc</gtr:id><gtr:otherNames>Uttenthal B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-1048</gtr:issn><gtr:outcomeId>5461feced8ad72.96654439</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E934508-1190-4318-BBAA-2CA61FE1FBF5</gtr:id><gtr:title>Development of an Escherichia coli expressing listeriolysin-O vaccine against Wilms tumor gene 1-expressing tumors.</gtr:title><gtr:parentPublicationTitle>Journal of immunotherapy (Hagerstown, Md. : 1997)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49a790dd5935ea90a9bd132b1df62812"><gtr:id>49a790dd5935ea90a9bd132b1df62812</gtr:id><gtr:otherNames>Dai MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1524-9557</gtr:issn><gtr:outcomeId>HUeQv4yvUwY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9072AB0B-4076-4298-BE58-A389402E1687</gtr:id><gtr:title>Analysis of the human immunodeficiency virus type 1 M group Vpu domains involved in antagonizing tetherin.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9db46c5b7405794c0889d48fee503e50"><gtr:id>9db46c5b7405794c0889d48fee503e50</gtr:id><gtr:otherNames>Petit SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>ZQFKbj4WVYT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>465A0208-AA74-4877-BC65-360E7517FBB6</gtr:id><gtr:title>DC priming by M. vaccae inhibits Th2 responses in contrast to specific TLR2 priming and is associated with selective activation of the CREB pathway.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5ada59437f6265f4c2952eb2c8878e9"><gtr:id>f5ada59437f6265f4c2952eb2c8878e9</gtr:id><gtr:otherNames>Le Bert N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>g9mMwkrxbQy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C873655-6D72-4EAB-8FEA-CC2EA6C5980C</gtr:id><gtr:title>CPSF6 defines a conserved capsid interface that modulates HIV-1 replication.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a6beffb1b3dfaecfccd9f955cc3b231"><gtr:id>2a6beffb1b3dfaecfccd9f955cc3b231</gtr:id><gtr:otherNames>Price AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_13996_26_22956906</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE8790D0-78D2-48FE-B94A-6F0864B5664B</gtr:id><gtr:title>Upregulation of TRIM5a gene expression after live-attenuated simian immunodeficiency virus vaccination in Mauritian cynomolgus macaques, but TRIM5a genotype has no impact on virus acquisition or vaccination outcome.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d601c726d34be556fecbbd27cb08186"><gtr:id>2d601c726d34be556fecbbd27cb08186</gtr:id><gtr:otherNames>Mattiuzzo G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>pm_13996_26_23152371</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6D9BA0F-C26C-4AFE-8BE7-2697B97468B3</gtr:id><gtr:title>Chemical toxicity to keratinocytes triggers dendritic cell activation via an IL-1a path.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42d8c6ca8786a190e5c6d4f3de1426de"><gtr:id>42d8c6ca8786a190e5c6d4f3de1426de</gtr:id><gtr:otherNames>Matjeka T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>TwKdk9GurSk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36B075B4-D66A-4C6F-8A6B-CA5B6DC885E3</gtr:id><gtr:title>Early biodistribution and persistence of a protective live attenuated SIV vaccine elicits localised innate responses in multiple lymphoid tissues.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02766ea99fdc02271ba31905900e4123"><gtr:id>02766ea99fdc02271ba31905900e4123</gtr:id><gtr:otherNames>Ferguson D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>545ce648427cc1.54108412</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85748E85-0FDF-4F46-938F-4C39E0E155DD</gtr:id><gtr:title>Transcriptional profiling of innate and adaptive human immune responses to mycobacteria in the tuberculin skin test.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95729c2d3a47703ec5f65134a7553513"><gtr:id>95729c2d3a47703ec5f65134a7553513</gtr:id><gtr:otherNames>Tomlinson GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>Qkj9eF1v1ie</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E90072B-30F2-41C7-964A-8FC25A3E199A</gtr:id><gtr:title>Truncation of TRIM5 in the Feliformia explains the absence of retroviral restriction in cells of the domestic cat.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5127c337c4d35c97966a996e685b8462"><gtr:id>5127c337c4d35c97966a996e685b8462</gtr:id><gtr:otherNames>McEwan WA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>swaDkNcaqQB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F90D844-DE28-4F2E-93EF-D924C19BEB60</gtr:id><gtr:title>SAMHD1-dependent retroviral control and escape in mice.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f73bda9f22c7c74fa4a798aa3795187"><gtr:id>9f73bda9f22c7c74fa4a798aa3795187</gtr:id><gtr:otherNames>Rehwinkel J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>545cf430c3bb39.88718688</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31707780-FD5A-4D31-A7D2-1E9FF305E393</gtr:id><gtr:title>Gene therapy strategies to exploit TRIM derived restriction factors against HIV-1.</gtr:title><gtr:parentPublicationTitle>Viruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f89c7b4622f2153cac81da53204ade0e"><gtr:id>f89c7b4622f2153cac81da53204ade0e</gtr:id><gtr:otherNames>Chan E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1999-4915</gtr:issn><gtr:outcomeId>545cef60192577.23622094</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0037F4F-CB5C-43D7-9E8E-B65A3715D58D</gtr:id><gtr:title>Tetherin restricts herpes simplex virus 1 and is antagonized by glycoprotein M.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16e46d4f7f3d0fd5771d96152a22af04"><gtr:id>16e46d4f7f3d0fd5771d96152a22af04</gtr:id><gtr:otherNames>Blondeau C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>545cf0d84bdcb4.52927387</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ADBEE715-A068-4824-A9CD-4A8C61F65F30</gtr:id><gtr:title>HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c1631b90dc75345cf78ba845c220f14"><gtr:id>9c1631b90dc75345cf78ba845c220f14</gtr:id><gtr:otherNames>Breckpot K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>sn99z6pTLeo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70D97813-4EAD-429D-9C9B-5EFB1220C210</gtr:id><gtr:title>Heat shock protein 90 controls HIV-1 reactivation from latency.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16a723b10317ba9aca23158c9a6c8606"><gtr:id>16a723b10317ba9aca23158c9a6c8606</gtr:id><gtr:otherNames>Anderson I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>545b9c57bbc1f2.55365152</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE053A87-FEFA-43D8-8AB9-F98E98D692BC</gtr:id><gtr:title>Ovine TRIM5a can restrict visna/maedi virus.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5657dc368990f3b9334380f063e243aa"><gtr:id>5657dc368990f3b9334380f063e243aa</gtr:id><gtr:otherNames>J?uregui P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_13996_26_22696640</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>404A9C0D-0B3F-49E5-9D9B-2DC334EF1794</gtr:id><gtr:title>HIV-1 capsid undergoes coupled binding and isomerization by the nuclear pore protein NUP358.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c660668f7b12ef3922555af6a0e45cc5"><gtr:id>c660668f7b12ef3922555af6a0e45cc5</gtr:id><gtr:otherNames>Bichel K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>545cf2f6a667e1.20211898</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71628A11-0B4D-4FAF-BAF7-5DAA6C71BA69</gtr:id><gtr:title>Testing the theory of immune selection in cancers that break the rules of transplantation.</gtr:title><gtr:parentPublicationTitle>Cancer immunology, immunotherapy : CII</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2774e90a1162c72ad08d2d1856e176c"><gtr:id>c2774e90a1162c72ad08d2d1856e176c</gtr:id><gtr:otherNames>Fassati A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0340-7004</gtr:issn><gtr:outcomeId>qXnC33uyTXm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4B57B4B-CE2A-4AFF-8218-6B75FB802EE0</gtr:id><gtr:title>Short RNAs are transcribed from repressed polycomb target genes and interact with polycomb repressive complex-2.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78ce7ce6c34651c317706ca694dff341"><gtr:id>78ce7ce6c34651c317706ca694dff341</gtr:id><gtr:otherNames>Kanhere A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>gYPeaXtNMcz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC3AA748-3163-46B8-A5BE-E9E6B3936EAE</gtr:id><gtr:title>Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient.</gtr:title><gtr:parentPublicationTitle>Journal of hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd2ca761a141ca7db238491b9127a7d8"><gtr:id>bd2ca761a141ca7db238491b9127a7d8</gtr:id><gtr:otherNames>Qasim W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0168-8278</gtr:issn><gtr:outcomeId>5461fe2140e195.66589283</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF22E918-507C-436D-8CD7-55A3A6FB474C</gtr:id><gtr:title>RNA-seq analysis of host and viral gene expression highlights interaction between varicella zoster virus and keratinocyte differentiation.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f960dc64663392005f3fbcba53da956"><gtr:id>9f960dc64663392005f3fbcba53da956</gtr:id><gtr:otherNames>Jones M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>545ba41f40f0b9.51180893</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AADA6D72-6154-49B4-96FA-CCB99F4AF5AC</gtr:id><gtr:title>Error, reproducibility and sensitivity: a pipeline for data processing of Agilent oligonucleotide expression arrays.</gtr:title><gtr:parentPublicationTitle>BMC bioinformatics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3d356f7cfe1e9a97102f4025fe5a3215"><gtr:id>3d356f7cfe1e9a97102f4025fe5a3215</gtr:id><gtr:otherNames>Chain B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1471-2105</gtr:issn><gtr:outcomeId>hXDWqLZomGw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9FF4DF3-F865-40A4-BEF6-D9F585267A1C</gtr:id><gtr:title>Adherent human alveolar macrophages exhibit a transient pro-inflammatory profile that confounds responses to innate immune stimulation.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95729c2d3a47703ec5f65134a7553513"><gtr:id>95729c2d3a47703ec5f65134a7553513</gtr:id><gtr:otherNames>Tomlinson GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13996_26_22768282</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2247BAA6-7E02-460F-A8AF-AFBCD81023B6</gtr:id><gtr:title>Active site remodeling switches HIV specificity of antiretroviral TRIMCyp.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a6beffb1b3dfaecfccd9f955cc3b231"><gtr:id>2a6beffb1b3dfaecfccd9f955cc3b231</gtr:id><gtr:otherNames>Price AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>kptoawAquR1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2DD6FC18-4BD5-4C7D-94E9-D40BE8B763A6</gtr:id><gtr:title>Epitope spreading contributes to effective immunotherapy in metastatic melanoma patients.</gtr:title><gtr:parentPublicationTitle>Immunotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f26c68aa9ecea466134c7126ebe179aa"><gtr:id>f26c68aa9ecea466134c7126ebe179aa</gtr:id><gtr:otherNames>Hardwick N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1750-743X</gtr:issn><gtr:outcomeId>J2HwQSuemJZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95C5F61E-F1A8-4B5F-993C-D95379476052</gtr:id><gtr:title>Transmissible [corrected] dog cancer genome reveals the origin and history of an ancient cell lineage.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9fe58dc6a098327a26c6ec7f9af7dc38"><gtr:id>9fe58dc6a098327a26c6ec7f9af7dc38</gtr:id><gtr:otherNames>Murchison EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>545b9cb3576192.99381322</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF8330DD-2A89-4DA7-AD99-8609C68C6DB8</gtr:id><gtr:title>Leishmania-specific surface antigens show sub-genus sequence variation and immune recognition.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03f50fdda9533c73c407c979b78d57e2"><gtr:id>03f50fdda9533c73c407c979b78d57e2</gtr:id><gtr:otherNames>Depledge DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>cgSbQoqK2xh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17F2BEE4-DC1A-41EC-AE41-0559CE33DDD0</gtr:id><gtr:title>No evidence of XMRV or related retroviruses in a London HIV-1-positive patient cohort.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0788e79a32e1e1b065a44e20d7ea9c5"><gtr:id>f0788e79a32e1e1b065a44e20d7ea9c5</gtr:id><gtr:otherNames>Gray ER</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>LaSepeL8Cdf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C735C09-0E96-4928-97BD-4BB4FFA72FB0</gtr:id><gtr:title>Methods of preparation and analysis of intracellular reverse transcription complexes.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2774e90a1162c72ad08d2d1856e176c"><gtr:id>c2774e90a1162c72ad08d2d1856e176c</gtr:id><gtr:otherNames>Fassati A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>jDRyaS6KkM4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF885001-F95C-479D-915A-E755E69DCBCA</gtr:id><gtr:title>Hare TRIM5a restricts divergent retroviruses and exhibits significant sequence variation from closely related lagomorpha TRIM5 genes.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4163edd090b7f7934101c6c7f3ffd2b9"><gtr:id>4163edd090b7f7934101c6c7f3ffd2b9</gtr:id><gtr:otherNames>Fletcher AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>E2YwNMNGvrF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D6BECE9-FC77-4105-A3F0-09C932D714C7</gtr:id><gtr:title>4-1BB ligand activates bystander dendritic cells to enhance immunization in trans.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e8005ca9db27435e99e117da5712d43"><gtr:id>5e8005ca9db27435e99e117da5712d43</gtr:id><gtr:otherNames>Macdonald DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>544fbc32a45524.97945788</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F46C68AD-75A8-4440-A605-6A413E6DE8E4</gtr:id><gtr:title>The HTR1A and HTR1B receptor genes influence stress-related information processing.</gtr:title><gtr:parentPublicationTitle>European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90b622be61f8011765e78c73253ee9a3"><gtr:id>90b622be61f8011765e78c73253ee9a3</gtr:id><gtr:otherNames>Mekli K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0924-977X</gtr:issn><gtr:outcomeId>kVFcJZonaWG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8081986F-37D5-423B-A85E-D4E47548EA41</gtr:id><gtr:title>The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/044f5e57988afec3522ce0a8b7ff48fe"><gtr:id>044f5e57988afec3522ce0a8b7ff48fe</gtr:id><gtr:otherNames>Pardieu C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>dAffjCsMEa4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85B06A5E-00D6-4177-95FF-D8212B6ACCB8</gtr:id><gtr:title>Human MHC Class I-restricted high avidity CD4T cells generated by co-transfer of TCR and CD8 mediate efficient tumor rejection in vivo.</gtr:title><gtr:parentPublicationTitle>Oncoimmunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ae03fe329f6f39f6142945d9f563e49"><gtr:id>6ae03fe329f6f39f6142945d9f563e49</gtr:id><gtr:otherNames>Xue SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2162-4011</gtr:issn><gtr:outcomeId>5461ff8162a007.66780775</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B20A959B-7A5F-4970-A755-074923676076</gtr:id><gtr:title>Ten years of progress in vaccination against cancer: the need to counteract cancer evasion by dual targeting in future therapies.</gtr:title><gtr:parentPublicationTitle>Cancer immunology, immunotherapy : CII</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b3a3adedd0a4c591c660bb492c735948"><gtr:id>b3a3adedd0a4c591c660bb492c735948</gtr:id><gtr:otherNames>Alpizar YA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0340-7004</gtr:issn><gtr:outcomeId>kCdaRrupWbw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97094BC2-3BB1-4BDF-8747-D1B858010E4A</gtr:id><gtr:title>Porcine endogenous retroviruses PERV A and A/C recombinant are insensitive to a range of divergent mammalian TRIM5alpha proteins including human TRIM5alpha.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae44d82633c36fa9eba6e8c8a9005700"><gtr:id>ae44d82633c36fa9eba6e8c8a9005700</gtr:id><gtr:otherNames>Wood A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>PN4YUUDZgbQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C41AD59-9C37-4D79-B3E7-CCBC2847A4E4</gtr:id><gtr:title>Hypochlorous acid: a natural adjuvant that facilitates antigen processing, cross-priming, and the induction of adaptive immunity.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d0b5306dd5fb8220a08bc0018485729"><gtr:id>5d0b5306dd5fb8220a08bc0018485729</gtr:id><gtr:otherNames>Prokopowicz ZM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>VmyUfqo164g</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B53319E-15B5-4129-9570-2DAAD7EDCCCC</gtr:id><gtr:title>Inhibition of HIV-1 replication by isoxazolidine and isoxazole sulfonamides.</gtr:title><gtr:parentPublicationTitle>Chemical biology &amp; drug design</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/257c231a152a044c321cbb42b71acaa1"><gtr:id>257c231a152a044c321cbb42b71acaa1</gtr:id><gtr:otherNames>Loh B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1747-0277</gtr:issn><gtr:outcomeId>psFxjR3ofws</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD8C70FE-ADFE-4FC7-BC13-4F149AA2DC60</gtr:id><gtr:title>Harnessing alveolar macrophages for sustained mucosal T-cell recall confers long-term protection to mice against lethal influenza challenge without clinical disease.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e8005ca9db27435e99e117da5712d43"><gtr:id>5e8005ca9db27435e99e117da5712d43</gtr:id><gtr:otherNames>Macdonald DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn><gtr:outcomeId>5462276a00fcb7.31134393</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>848F1309-87CB-49BF-AE12-009E412754A7</gtr:id><gtr:title>Monsef Benkirane awarded 2013 Ming K. Jeang Foundation Retrovirology Prize: landmark HIV-1 research honoured.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1806d57777bec30b4d217f5aa67467e"><gtr:id>c1806d57777bec30b4d217f5aa67467e</gtr:id><gtr:otherNames>Berkhout B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>545b9d0ec101e2.12860597</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F673B615-6D46-43CA-ABFC-0B686578A4E3</gtr:id><gtr:title>Transportin 3 promotes a nuclear maturation step required for efficient HIV-1 integration.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/240a27c7bd5d10365eaae398f59768ee"><gtr:id>240a27c7bd5d10365eaae398f59768ee</gtr:id><gtr:otherNames>Zhou L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>oEPVm2oX3Xq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D49786DA-14DE-4086-BEC9-04E32BABEB47</gtr:id><gtr:title>Escape from R-peptide deletion in a ?-retrovirus.</gtr:title><gtr:parentPublicationTitle>Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd0712031dc167bd02265b80cf8e7e07"><gtr:id>fd0712031dc167bd02265b80cf8e7e07</gtr:id><gtr:otherNames>Schneider IC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0042-6822</gtr:issn><gtr:outcomeId>MqpGbSrMspK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>218990FE-ADF2-4CED-8B81-9E8F0C070FDD</gtr:id><gtr:title>Early antigen presentation of protective HIV-1 KF11Gag and KK10Gag epitopes from incoming viral particles facilitates rapid recognition of infected cells by specific CD8+ T cells.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5c2d35d76a3ff3436246776122a7aa9"><gtr:id>f5c2d35d76a3ff3436246776122a7aa9</gtr:id><gtr:otherNames>Kl?verpris HN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>545cf71c966f37.69980824</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F574D8EF-E9FD-4D19-B280-3AC530872B1D</gtr:id><gtr:title>Structural basis for nuclear import of splicing factors by human Transportin 3.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67c749d627f6a6bccbe386923cc5a048"><gtr:id>67c749d627f6a6bccbe386923cc5a048</gtr:id><gtr:otherNames>Maertens GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>545b9c82716285.11668961</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01879F7D-DFF2-4DE2-BAB7-1FE49C49CC41</gtr:id><gtr:title>Effect of the internal promoter on insertional gene activation by lentiviral vectors with an intact HIV long terminal repeat.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/387e56f534a8a1ecfad6114c7f9cb2ae"><gtr:id>387e56f534a8a1ecfad6114c7f9cb2ae</gtr:id><gtr:otherNames>Knight S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>kBHqfgNCErn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B9ACC72-69B3-4A00-BB4D-B14638F6F98F</gtr:id><gtr:title>A model for cofactor use during HIV-1 reverse transcription and nuclear entry.</gtr:title><gtr:parentPublicationTitle>Current opinion in virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d849bcff7512ae0e8f595615237a927"><gtr:id>7d849bcff7512ae0e8f595615237a927</gtr:id><gtr:otherNames>Hilditch L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1879-6257</gtr:issn><gtr:outcomeId>545ceeaa89d427.79976674</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>858564C6-1DE6-45DA-ABBB-1DEDBB36CFA0</gtr:id><gtr:title>Comparison of lentiviral and sleeping beauty mediated a? T cell receptor gene transfer.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/650f1d8cfe4962f9cd8bede5aa155319"><gtr:id>650f1d8cfe4962f9cd8bede5aa155319</gtr:id><gtr:otherNames>Field AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>546202c21bc206.65344493</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>004AE559-8797-4BE7-A345-03D5D4107DDC</gtr:id><gtr:title>Early potent protection against heterologous SIVsmE660 challenge following live attenuated SIV vaccination in Mauritian cynomolgus macaques.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3dd8773027f8192fe964ca758e49a370"><gtr:id>3dd8773027f8192fe964ca758e49a370</gtr:id><gtr:otherNames>Berry N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13996_26_21853072</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C984CB38-90F0-4F87-AA5E-7A1948E9680D</gtr:id><gtr:title>Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1468a3c79a930345b1162a38bc32d1aa"><gtr:id>1468a3c79a930345b1162a38bc32d1aa</gtr:id><gtr:otherNames>Gupta RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>BA1043BD312</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00A6FDC8-E3F0-4BAC-8C31-5FB01805F7C8</gtr:id><gtr:title>HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ede923f969c5ec692b719203d38f9dc6"><gtr:id>ede923f969c5ec692b719203d38f9dc6</gtr:id><gtr:otherNames>Ocwieja KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>qN4PeA1L1Be</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A2C0499-EC26-4F73-B9E9-D9DDA2090BD6</gtr:id><gtr:title>Development of a Wilms' tumor antigen-specific T-cell receptor for clinical trials: engineered patient's T cells can eliminate autologous leukemia blasts in NOD/SCID mice.</gtr:title><gtr:parentPublicationTitle>Haematologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ae03fe329f6f39f6142945d9f563e49"><gtr:id>6ae03fe329f6f39f6142945d9f563e49</gtr:id><gtr:otherNames>Xue SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0390-6078</gtr:issn><gtr:outcomeId>ZFG3tQmp52E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1319E5E-D61C-4A56-A6A2-8202D3D4F6F7</gtr:id><gtr:title>A quantitative proteomics design for systematic identification of protease cleavage events.</gtr:title><gtr:parentPublicationTitle>Molecular &amp; cellular proteomics : MCP</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad1854c2a320f5fe8bd8170f93543b53"><gtr:id>ad1854c2a320f5fe8bd8170f93543b53</gtr:id><gtr:otherNames>Impens F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1535-9476</gtr:issn><gtr:outcomeId>CYfkjRaVHCS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E7DB55F-D6AA-4AB5-8837-4142371C84F0</gtr:id><gtr:title>No evidence of XMRV in prostate cancer cohorts in the Midwestern United States.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cac4a32cea8345e9a184ca5f2dc240f"><gtr:id>5cac4a32cea8345e9a184ca5f2dc240f</gtr:id><gtr:otherNames>Sakuma T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>RNK8H7vPatE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67834AE8-C797-4E1F-8BF3-1DDF9B213CB5</gtr:id><gtr:title>Gyrase B inhibitor impairs HIV-1 replication by targeting Hsp90 and the capsid protein.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf29f7227bad6014781959a7fbeeeb53"><gtr:id>bf29f7227bad6014781959a7fbeeeb53</gtr:id><gtr:otherNames>Vozzolo L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>eJr4HtTkcGQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E389553-AD80-4E87-851D-D0335642F6B6</gtr:id><gtr:title>Diversity of TRIM5a and TRIMCyp sequences in cynomolgus macaques from different geographical origins.</gtr:title><gtr:parentPublicationTitle>Immunogenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f6ba1b9e95629587f1143575d6b64393"><gtr:id>f6ba1b9e95629587f1143575d6b64393</gtr:id><gtr:otherNames>Berry NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0093-7711</gtr:issn><gtr:outcomeId>pm_13996_26_22124667</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E88FC90-22BA-48BB-96E0-5F15A8C8E4D5</gtr:id><gtr:title>Interactions between HIV-1 and the cell-autonomous innate immune system.</gtr:title><gtr:parentPublicationTitle>Cell host &amp; microbe</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9d8dc102629560a2c32a6e4c03990a0"><gtr:id>c9d8dc102629560a2c32a6e4c03990a0</gtr:id><gtr:otherNames>Towers GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1931-3128</gtr:issn><gtr:outcomeId>545ce8c5b780d7.14999633</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5620D0DF-77A0-40F3-81F7-8DD016234B95</gtr:id><gtr:title>Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21).</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c71af6e6a5f6449faafda0c5b494a1f3"><gtr:id>c71af6e6a5f6449faafda0c5b494a1f3</gtr:id><gtr:otherNames>Mallery DL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>HsKQDDEt34e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82DEEFAE-1769-41BD-B098-C57D63A1A527</gtr:id><gtr:title>Obituary: Kuan-Teh Jeang.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1806d57777bec30b4d217f5aa67467e"><gtr:id>c1806d57777bec30b4d217f5aa67467e</gtr:id><gtr:otherNames>Berkhout B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>545b9ce25dc589.14488349</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6F8BA77-CEA4-4373-BF76-A653C1EABB7E</gtr:id><gtr:title>Next-generation whole genome sequencing identifies the direction of norovirus transmission in linked patients.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c18528a81eb674069f4bfa80db10e10c"><gtr:id>c18528a81eb674069f4bfa80db10e10c</gtr:id><gtr:otherNames>Kundu S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>545ba609eca5c9.06288860</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DE96FEC-E71F-4D77-84D1-1339940C6BF5</gtr:id><gtr:title>Immunomodulation in the treatment of haematological malignancies.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a76e897c6e4a3f2ef62352c6e32d06d"><gtr:id>4a76e897c6e4a3f2ef62352c6e32d06d</gtr:id><gtr:otherNames>Cesco-Gaspere M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1591-8890</gtr:issn><gtr:outcomeId>cCMvJUGRYf9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00A4C191-08CA-40D7-A1A6-5384EB363922</gtr:id><gtr:title>Mode of virus rescue determines the acquisition of VHS mutations in VP22-negative herpes simplex virus 1.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a487439957a8a457771f1264aa85442"><gtr:id>0a487439957a8a457771f1264aa85442</gtr:id><gtr:otherNames>Ebert K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>545ba859051401.20404011</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB1C4AB9-0544-4FF7-9BC6-F09AADD6BBAA</gtr:id><gtr:title>Feline tetherin efficiently restricts release of feline immunodeficiency virus but not spreading of infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f25e8a22839c8eaf9492900e3ab52a36"><gtr:id>f25e8a22839c8eaf9492900e3ab52a36</gtr:id><gtr:otherNames>Dietrich I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>C6hNebi4wh3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83B2C09C-09B1-4FD6-B5F2-517F64617F0E</gtr:id><gtr:title>A lentiviral vector pseudotype suitable for vaccine development.</gtr:title><gtr:parentPublicationTitle>The journal of gene medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d7ce540024a50b8bd8ff7d2427850e4"><gtr:id>6d7ce540024a50b8bd8ff7d2427850e4</gtr:id><gtr:otherNames>Lopes L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1099-498X</gtr:issn><gtr:outcomeId>DV9oAw4PRZV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A52A3AB3-E238-4FA2-B9A8-CC1D0899CC55</gtr:id><gtr:title>Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41d7ef596be4b3c17e86a591d669f56b"><gtr:id>41d7ef596be4b3c17e86a591d669f56b</gtr:id><gtr:otherNames>Wright GP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>sQkGwNm4Afy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B68D9CC-2032-4D9B-8C1D-007E629BA2EF</gtr:id><gtr:title>Gag determinants of fitness and drug susceptibility in protease inhibitor-resistant human immunodeficiency virus type 1.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2046d415c257b2fe0d1ecb7aa072c4d1"><gtr:id>2046d415c257b2fe0d1ecb7aa072c4d1</gtr:id><gtr:otherNames>Parry CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>maCria1nVS1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75595C9A-4431-4061-9E98-8E7240410761</gtr:id><gtr:title>Phylogenetic analysis of murine leukemia virus sequences from longitudinally sampled chronic fatigue syndrome patients suggests PCR contamination rather than viral evolution.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1726215f97cf2a56089d86c8d135545"><gtr:id>d1726215f97cf2a56089d86c8d135545</gtr:id><gtr:otherNames>Katzourakis A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>oXvLLbNvJm7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0546A52-E0E2-4214-9158-DB16C18654E0</gtr:id><gtr:title>HIV-1 evades innate immune recognition through specific cofactor recruitment.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34c1e8ababaaac31f24b1fb218be5bbb"><gtr:id>34c1e8ababaaac31f24b1fb218be5bbb</gtr:id><gtr:otherNames>Rasaiyaah J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>545cf024a9da14.90917005</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4517190-63B0-4293-BEF4-662A8F1ABE1C</gtr:id><gtr:title>Molecular immunology lessons from therapeutic T-cell receptor gene transfer.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c31326fe2d7119af01381f29a5e77427"><gtr:id>c31326fe2d7119af01381f29a5e77427</gtr:id><gtr:otherNames>Thomas S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>CowJkJxjBpK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7E50231-91EF-48FB-9804-29F5DE60BE0A</gtr:id><gtr:title>Lentiviral vectors targeted to MHC II are effective in immunization.</gtr:title><gtr:parentPublicationTitle>Human gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fe67292440a9860f2973e2f2b6ede31"><gtr:id>0fe67292440a9860f2973e2f2b6ede31</gtr:id><gtr:otherNames>Ageichik A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1043-0342</gtr:issn><gtr:outcomeId>NirCNkmY14d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C347AD37-5B7E-4212-8FA7-19644AE39CEB</gtr:id><gtr:title>Diverse HIV viruses are targeted by a conformationally dynamic antiviral.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6994fc2e6e840b1c3dc3b989e831439"><gtr:id>d6994fc2e6e840b1c3dc3b989e831439</gtr:id><gtr:otherNames>Caines ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>pm_13996_26_22407016</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1BE40901-F382-4C45-A509-DE204546716C</gtr:id><gtr:title>Genome Sequence of Human Herpesvirus 7 Strain UCL-1.</gtr:title><gtr:parentPublicationTitle>Genome announcements</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/445e89510add42a0b7afe91dfd55d3ee"><gtr:id>445e89510add42a0b7afe91dfd55d3ee</gtr:id><gtr:otherNames>Donaldson CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>545ba70ba03f76.49983207</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>221C1F84-7281-49DA-BB83-88DBC43A53FD</gtr:id><gtr:title>Impact of the N348I mutation in HIV-1 reverse transcriptase on nonnucleoside reverse transcriptase inhibitor resistance in non-subtype B HIV-1.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a115fb22ae8b5eb1d761afe50087d24"><gtr:id>9a115fb22ae8b5eb1d761afe50087d24</gtr:id><gtr:otherNames>McCormick AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>odR7z2YgdVT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA2B0F17-F29C-4816-B8AD-2F7420C774ED</gtr:id><gtr:title>DNA fusion vaccine designs to induce tumor-lytic CD8+ T-cell attack via the immunodominant cysteine-containing epitope of NY-ESO 1.</gtr:title><gtr:parentPublicationTitle>International journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/442b429f6b5f836091635bace93c3863"><gtr:id>442b429f6b5f836091635bace93c3863</gtr:id><gtr:otherNames>Campos-Perez J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0020-7136</gtr:issn><gtr:outcomeId>54622623713e18.18968055</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F355CFE-57B8-4338-A055-CB2686083BE6</gtr:id><gtr:title>TriTrypDB: a functional genomic resource for the Trypanosomatidae.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bdc3d43308c9cdef99af1a55f2556f74"><gtr:id>bdc3d43308c9cdef99af1a55f2556f74</gtr:id><gtr:otherNames>Aslett M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>qzzx9xisV6e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1CF0A6DC-0EAB-42ED-995E-D1C79927BB5B</gtr:id><gtr:title>The impact of DNA topology on polyplex uptake and transfection efficiency in mammalian cells.</gtr:title><gtr:parentPublicationTitle>Journal of biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6957c278545d5de8c579b913a19c47c3"><gtr:id>6957c278545d5de8c579b913a19c47c3</gtr:id><gtr:otherNames>Dhanoya A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0168-1656</gtr:issn><gtr:outcomeId>KFsPdMSHUz2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95E51FA9-4415-4537-9689-5C45EF24D97D</gtr:id><gtr:title>Conformational adaptation of Asian macaque TRIMCyp directs lineage specific antiviral activity.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5535e5b095530624beba13046aa94cd9"><gtr:id>5535e5b095530624beba13046aa94cd9</gtr:id><gtr:otherNames>Ylinen LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>qGApW7EAonY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>169E6ADF-DD62-4A0C-A591-E6D51FD820DE</gtr:id><gtr:title>Generation of multi-functional antigen-specific human T-cells by lentiviral TCR gene transfer.</gtr:title><gtr:parentPublicationTitle>Gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b999bff29ae3584c98fe490444298f8b"><gtr:id>b999bff29ae3584c98fe490444298f8b</gtr:id><gtr:otherNames>Perro M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0969-7128</gtr:issn><gtr:outcomeId>syrbx4hTc9w</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16D15096-64A6-4F2F-B9E2-6AEFD0C6AA64</gtr:id><gtr:title>p38 signaling inhibits mTORC1-independent autophagy in senescent human CD8? T cells.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eeadefcfa805429fe4021215f24d5f0f"><gtr:id>eeadefcfa805429fe4021215f24d5f0f</gtr:id><gtr:otherNames>Henson SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>54621ad0047f29.65636332</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01985481-FC25-48A6-9F3A-F367BF9AD5CB</gtr:id><gtr:title>Differential requirement for cathepsin D for processing of the full length and C-terminal fragment of the malaria antigen MSP1.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a72f69a17c5546c6057221e2636df10"><gtr:id>9a72f69a17c5546c6057221e2636df10</gtr:id><gtr:otherNames>Tulone C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>MSHBrKN6XNv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A22FF8F-7BF5-4E5F-A194-52B8A68DB51D</gtr:id><gtr:title>Selective ERK activation differentiates mouse and human tolerogenic dendritic cells, expands antigen-specific regulatory T cells, and suppresses experimental inflammatory arthritis.</gtr:title><gtr:parentPublicationTitle>Arthritis and rheumatism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e06e317fad1d8db4dee8b7c2ff53fba"><gtr:id>8e06e317fad1d8db4dee8b7c2ff53fba</gtr:id><gtr:otherNames>Arce F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0004-3591</gtr:issn><gtr:outcomeId>gnr3JDuFzoP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FC99688-5AF9-431F-9F15-E494E9ABC8E6</gtr:id><gtr:title>IL-2 regulates expression of C-MAF in human CD4 T cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4bd41f5e795706d066b9db464defb69"><gtr:id>d4bd41f5e795706d066b9db464defb69</gtr:id><gtr:otherNames>Rani A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>RV1boh8LaQz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B53F3943-A01B-48C0-8286-B484CF575E89</gtr:id><gtr:title>Disease-associated XMRV sequences are consistent with laboratory contamination.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d0e4078101e2913852def3cc79eff29"><gtr:id>0d0e4078101e2913852def3cc79eff29</gtr:id><gtr:otherNames>Hu? S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>96CFC021_296CFC021_2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>295621DC-261A-4C1C-AB9F-C482F25CF30A</gtr:id><gtr:title>HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b80e4206e65c27027c5eb4c5816ed08"><gtr:id>2b80e4206e65c27027c5eb4c5816ed08</gtr:id><gtr:otherNames>Schaller T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_13996_26_22174692</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F881876-A439-47FD-9EA0-A5AB4631E521</gtr:id><gtr:title>Innate immunity against HIV: a priority target for HIV prevention research.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f6b6ae8702947976cd643c36a0d0bf5d"><gtr:id>f6b6ae8702947976cd643c36a0d0bf5d</gtr:id><gtr:otherNames>Borrow P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>AkmW1MpKmAD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D366835B-E03A-44FB-8DE9-1B1ACB98A869</gtr:id><gtr:title>HIV-1 infection of macrophages is dependent on evasion of innate immune cellular activation.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfe8677cb938dc1232570dc209d4c71e"><gtr:id>cfe8677cb938dc1232570dc209d4c71e</gtr:id><gtr:otherNames>Tsang J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>NUTywM1V2sZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0FEFA2E-D6EB-478F-8BEE-451B60A22D66</gtr:id><gtr:title>HLA-specific intracellular epitope processing shapes an immunodominance pattern for HLA-B*57 that is distinct from HLA-B*58:01.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5c2d35d76a3ff3436246776122a7aa9"><gtr:id>f5c2d35d76a3ff3436246776122a7aa9</gtr:id><gtr:otherNames>Kl?verpris HN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>545cf52f9bafc6.36771342</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB39BAE5-984A-44DB-8460-EB6CB36A265B</gtr:id><gtr:title>A tail of Tetherin: how pandemic HIV-1 conquered the world.</gtr:title><gtr:parentPublicationTitle>Cell host &amp; microbe</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1468a3c79a930345b1162a38bc32d1aa"><gtr:id>1468a3c79a930345b1162a38bc32d1aa</gtr:id><gtr:otherNames>Gupta RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1931-3128</gtr:issn><gtr:outcomeId>qTQ7Gf1Ztme</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D285BA4-8146-4F7F-B3A0-BABF108B1822</gtr:id><gtr:title>Restriction of retroviral replication by APOBEC3G/F and TRIM5alpha.</gtr:title><gtr:parentPublicationTitle>Trends in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a22858f758e08c8666a044713dd48bb7"><gtr:id>a22858f758e08c8666a044713dd48bb7</gtr:id><gtr:otherNames>Huthoff H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0966-842X</gtr:issn><gtr:outcomeId>pm_13996_16_18976920</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3AC9A66-FE4D-401A-8FCC-8706A3B107EE</gtr:id><gtr:title>Vpx complementation of 'non-macrophage tropic' R5 viruses reveals robust entry of infectious HIV-1 cores into macrophages.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/292b41fa56f474420b9e8bde21def9a9"><gtr:id>292b41fa56f474420b9e8bde21def9a9</gtr:id><gtr:otherNames>Mlcochova P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>545ce9c12b7844.43410502</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16A57A7D-BC47-470A-8101-4111B03B6742</gtr:id><gtr:title>From Duke to King's: Michael Malim wins the 2010 Retrovirology Prize.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2774e90a1162c72ad08d2d1856e176c"><gtr:id>c2774e90a1162c72ad08d2d1856e176c</gtr:id><gtr:otherNames>Fassati A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>fipKiqFAVb3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36BEB1BA-4EE1-42ED-A355-94994D668952</gtr:id><gtr:title>Full-length HIV-1 Gag determines protease inhibitor susceptibility within in vitro assays.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1468a3c79a930345b1162a38bc32d1aa"><gtr:id>1468a3c79a930345b1162a38bc32d1aa</gtr:id><gtr:otherNames>Gupta RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>mhb2rKxm8yB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28D24253-C180-4FBC-8D89-DCB517E47F78</gtr:id><gtr:title>Analysis of XMRV integration sites from human prostate cancer tissues suggests PCR contamination rather than genuine human infection.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b5ae5ab08033b049c445101cf1d5a87"><gtr:id>9b5ae5ab08033b049c445101cf1d5a87</gtr:id><gtr:otherNames>Garson JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>XkwAfrtr9BN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9423E4F6-A112-4D82-B107-E99E8AB13926</gtr:id><gtr:title>Identification of a RELIK orthologue in the European hare (Lepus europaeus) reveals a minimum age of 12 million years for the lagomorph lentiviruses.</gtr:title><gtr:parentPublicationTitle>Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/303c119beb542abcde81d023f6f3fef2"><gtr:id>303c119beb542abcde81d023f6f3fef2</gtr:id><gtr:otherNames>Keckesova Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0042-6822</gtr:issn><gtr:outcomeId>pm_13996_16_19070882</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3BAEF010-10EB-4BF6-9AE3-E896A1E0448B</gtr:id><gtr:title>HIV-1 exploits importin 7 to maximize nuclear import of its DNA genome.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9ff52e24b05f5b2cf2786523be6ff84"><gtr:id>d9ff52e24b05f5b2cf2786523be6ff84</gtr:id><gtr:otherNames>Zaitseva L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>Roc2TauARzh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E09BEBB8-B95C-49F3-A6A7-F17EF0CB621B</gtr:id><gtr:title>TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67f6a49d89030d49da8ab007e4a081ae"><gtr:id>67f6a49d89030d49da8ab007e4a081ae</gtr:id><gtr:otherNames>Di Pietro A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>545cf675846cb4.54365678</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G9721629</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>80</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>